Publications by authors named "Matthijs Scheltema"

Claim this Profile
P
Prospective Multicentre Validation of Focal Irreversible Electroporation as an Attractive Treatment Option for Localised Intermediate-risk Prostate Cancer.
Matthijs J V Scheltema, Phillip D Stricker

Eur Urol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of unipolar major depression in prostate cancer patients undergoing androgen deprivation therapy: The impact of age, treatment duration and prostate cancer stage.
Amy L Holtman, Sabine van Leersum, Karen S van den Berg, Lea M Dijksman, Whitney M Freeze, Matthijs J V Scheltema

J Psychosom Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer.
Tessa D Van Bergen, Arthur J A T Braat, Rick Hermsen, Joris G Heetman, Lieke Wever, Matthijs J Scheltema

Eur J Nucl Med Mol Imaging· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of short term surgical outcomes of radical prostatectomy in the decade following the introduction of minimum volume standards in the Netherlands.
Caroline M van der Starre, Katja K H Aben, Pim J van Leeuwen, Martijn B Busstra, Matthijs J V Scheltema

Urol Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of PSMA PET/CT-Based local staging in predicting biochemical recurrence after radical prostatectomy.
Vera Sweere, Alexandra Bruins Slot, Rick Hermsen, Joris G Heetman, Lieke Wever, Matthijs J V Scheltema

Eur J Nucl Med Mol Imaging· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Added Value of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography to Magnetic Resonance Imaging for Local Staging of Prostate Cancer in Patients Undergoing Radical Prostatectomy.
Timo F W Soeterik, Joris G Heetman, Rick Hermsen, Lieke Wever, Jules Lavalaye, Matthijs J Scheltema

Eur Urol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.
Bart Geboers, Matthijs J Scheltema, Jason Jung, Joyce Bakker, Florentine E F Timmer

BJU Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delphi consensus project on prostate-specific membrane antigen (PSMA)-targeted surgery-outcomes from an international multidisciplinary panel.
Anne-Claire Berrens, Matthijs Scheltema, Tobias Maurer, Ken Hermann, Freddie C Hamdy

Eur J Nucl Med Mol Imaging· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.
Bart Geboers, Dennie Meijer, William Counter, Alexandar Blazevski, James Thompson, Matthijs J Scheltema

BJU Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to 'Re: Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'.
Bart Geboers, Matthijs J V Scheltema, Louise Emmett, Phillip D Stricker

BJU Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic health record and research; happy marriage or early divorce?
Matthijs J Scheltema, Bas W G van Rhijn

BJU Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer.
Yves J L Bodar, Liselotte M S Boevé, Pim J van Leeuwen, Phillippe C Baars, Jakko A Nieuwenhuijzen, Matthijs J Scheltema

BJU Int· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study.
William Gondoputro, Paul Doan, Athos Katelaris, Matthijs J Scheltema, Bart Geboers

Transl Androl Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage irreversible electroporation for radio-recurrent prostate cancer.
Matthijs J Scheltema, Athos Katelaris, Phillip D Stricker

Nat Rev Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
Matthijs J Scheltema, Bart Geboers, Alexandar Blazevski, Paul Doan, Athos Katelaris

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage irreversible electroporation for radio-recurrent prostate cancer - the prospective FIRE trial.
Alexandar Blazevski, Bart Geboers, Matthijs J Scheltema, William Gondoputro, Paul Doan

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Median 4-year outcomes of salvage irreversible electroporation for localized radio-recurrent prostate cancer.
Bart Geboers, Matthijs J Scheltema, Alexandar Blazevski, Athos Katelaris, Paul Doan

BJU Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is It the Load That Breaks You or the Way You Carry It: How Demanding Is Endourology?
Michaël M E L Henderickx, Nora Hendriks, Joyce Baard, Harrie P Beerlage, Daphne T Boom, Matthijs J V Scheltema

J Endourol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer.
Paul Doan, Athos Katelaris, Matthijs J Scheltema, Andrew Hayen, Amer Amin

BMC Urol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines of guidelines: focal therapy for prostate cancer, is it time for consensus?
Sean Ong, Kenneth Chen, Jeremy Grummet, John Yaxley, Matthijs J Scheltema

BJU Int· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robot-Assisted Prostate-Specific Membrane Antigen-Radioguided Surgery in Primary Diagnosed Prostate Cancer.
William Gondoputro, Matthijs J Scheltema, Alexander Blazevski, Paul Doan, James E Thompson

J Nucl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
Luigi A M J G van Riel, Bart Geboers, Ertunc Kabaktepe, Alexander Blazevski, Daan J Reesink, Matthijs J Scheltema

BJU Int· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study.
Bart Geboers, William Gondoputro, James E Thompson, Daan J Reesink, Luigi A M J G van Riel, Matthijs J Scheltema

Eur Urol Focus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Analysis of the Magnetic Resonance Imaging in Active Surveillance Trial.
Paul Doan, Matthijs J Scheltema, Amer Amin, Ron Shnier, Bart Geboers

J Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Paul Doan, Matthijs J Scheltema, Amer Amin, Ron Shnier, Bart Geboers

J Urol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis